Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China
· Delayed Price · Currency is CNY 41.31
-0.16 (-0.39%)
Apr 29, 2026, 3:04 PM CST
SHE:300957 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2018 |
| Market Capitalization | 17,404 | 16,634 | 17,933 | 28,877 | 63,218 | 81,450 | Upgrade
|
| Market Cap Growth | -4.12% | -7.24% | -37.90% | -54.32% | -22.38% | - | Upgrade
|
| Enterprise Value | 14,253 | 13,650 | 15,685 | 25,475 | 60,808 | 77,959 | Upgrade
|
| Last Close Price | 41.31 | 39.33 | 41.83 | 66.03 | 143.31 | 183.99 | Upgrade
|
| PE Ratio | 32.18 | 32.89 | 35.65 | 38.16 | 60.13 | 94.39 | Upgrade
|
| Forward PE | 29.07 | 23.38 | 18.79 | 19.39 | 44.82 | 75.64 | Upgrade
|
| PS Ratio | 3.15 | 3.10 | 3.13 | 5.04 | 12.61 | 20.25 | Upgrade
|
| PB Ratio | 2.79 | 2.64 | 2.90 | 4.80 | 11.28 | 17.05 | Upgrade
|
| P/TBV Ratio | 3.31 | 3.13 | 3.28 | 5.50 | 11.55 | 17.36 | Upgrade
|
| P/FCF Ratio | 18.19 | 33.70 | 56.66 | 85.90 | 151.96 | 92.34 | Upgrade
|
| P/OCF Ratio | 16.00 | 17.03 | 25.81 | 47.31 | 82.16 | 70.66 | Upgrade
|
| PEG Ratio | - | 1.07 | 0.82 | 0.78 | 1.67 | 1.81 | Upgrade
|
| EV/Sales Ratio | 2.58 | 2.55 | 2.74 | 4.45 | 12.13 | 19.38 | Upgrade
|
| EV/EBITDA Ratio | 19.99 | 23.33 | 29.23 | 26.70 | 54.76 | 80.53 | Upgrade
|
| EV/EBIT Ratio | 26.85 | 28.71 | 37.28 | 28.83 | 57.79 | 82.20 | Upgrade
|
| EV/FCF Ratio | 14.90 | 27.65 | 49.56 | 75.78 | 146.17 | 88.39 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.13 | 0.13 | 0.04 | 0.02 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 1.30 | 1.27 | 1.34 | 0.21 | 0.10 | 0.12 | Upgrade
|
| Debt / FCF Ratio | 0.97 | 1.69 | 2.58 | 0.64 | 0.27 | 0.14 | Upgrade
|
| Net Debt / Equity Ratio | -0.53 | -0.55 | -0.55 | -0.57 | -0.77 | -0.88 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.16 | -5.94 | -6.37 | -3.59 | -3.88 | -4.36 | Upgrade
|
| Net Debt / FCF Ratio | -3.44 | -7.04 | -10.81 | -10.19 | -10.37 | -4.78 | Upgrade
|
| Asset Turnover | 0.70 | 0.64 | 0.73 | 0.81 | 0.80 | 1.09 | Upgrade
|
| Inventory Turnover | 2.59 | 2.46 | 2.07 | 1.86 | 2.23 | 2.73 | Upgrade
|
| Quick Ratio | 3.05 | 3.37 | 3.60 | 3.52 | 5.00 | 5.24 | Upgrade
|
| Current Ratio | 3.63 | 3.77 | 4.04 | 4.28 | 5.76 | 5.81 | Upgrade
|
| Return on Equity (ROE) | 8.79% | 8.27% | 8.11% | 13.07% | 20.24% | 28.90% | Upgrade
|
| Return on Assets (ROA) | 4.17% | 3.57% | 3.33% | 7.76% | 10.50% | 15.99% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.80% | 14.24% | 12.78% | 39.83% | 98.69% | 142.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.90% | 7.00% | 6.20% | 14.20% | 18.40% | 19.30% | Upgrade
|
| Earnings Yield | 3.12% | 3.04% | 2.80% | 2.62% | 1.66% | 1.06% | Upgrade
|
| FCF Yield | 5.50% | 2.97% | 1.76% | 1.16% | 0.66% | 1.08% | Upgrade
|
| Dividend Yield | 1.69% | 1.65% | 1.43% | 0.91% | 0.56% | 0.33% | Upgrade
|
| Payout Ratio | 66.46% | 52.53% | 52.19% | 44.81% | 24.18% | 22.09% | Upgrade
|
| Buyback Yield / Dilution | -1.96% | -0.53% | 0.85% | 0.27% | -4.15% | -13.09% | Upgrade
|
| Total Shareholder Return | -0.27% | 1.12% | 2.28% | 1.18% | -3.59% | -12.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.